Serial #79129639
LIVE

Serial Number

79129639

Owner

Genloci Biotechnologies Inc.

Filing Date

Dec 21, 2012

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79129639 Trademark

Serial Number: 79129639 • Registration: 4416601

Serial #79129639 is a trademark filed by Genloci Biotechnologies Inc. on December 21, 2012. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Genloci Biotechnologies Inc. (7 trademarks)

Floor 13-A, Bldg. 1

Entity Type: 03

Trademark Details

Filing Date

December 21, 2012

Registration Date

October 15, 2013

Published for Opposition

July 30, 2013

Cancellation Date

December 21, 2022

Goods & Services

Medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; bacterial and bacteriological preparations for medical or veterinary purposes; pharmaceutical products for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biological preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biochemical medicines for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; sterilising preparations; dietary and nutritional supplements for medical use; depuratives for the body

Protein in raw material form for scientific and medical research; enzymes for the brewing industry; enzymes for use in the textile industry; enzymes for use in the dairy industry; enzymes for use in the food industry; stain repellents for textiles; industrial chemicals; biochemical catalysts; chemical preparations for scientific purposes; chemical reagents, other than for medical or veterinary purpose; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use

Technical research in field of medicines and pharmaceuticals; technical project studies, namely, conducting of technical feasibility studies in field of medicines and pharmaceuticals; research and development of new products for others; quality control for others; product quality testing; pharmaceutical product quality evaluation; quality evaluation services for the medical and anesthesia industries; chemical research; bacteriological research; biological research

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Jul 20, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jul 20, 2023 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Mar 7, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 16, 2022 INTS
INVALIDATION PROCESSED
Feb 16, 2022 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 26, 2021 INTR
CANCELLED SECTION 71
Feb 26, 2021 C71T
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 12, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 21, 2014 FICS
FINAL DISPOSITION PROCESSED
Jan 21, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 15, 2014 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 15, 2013 R.PR
PUBLISHED FOR OPPOSITION
Jul 30, 2013 PUBO
NOTICE OF PUBLICATION
Jul 10, 2013 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 25, 2013 PREV
ASSIGNED TO LIE
Jun 24, 2013 ALIE
REFUSAL PROCESSED BY IB
Jun 19, 2013 RFNP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 6, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 6, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 5, 2013 TROA
APPLICATION FILING RECEIPT MAILED
Jun 1, 2013 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 29, 2013 RFCS
REFUSAL PROCESSED BY MPU
May 29, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 29, 2013 RFCR
NON-FINAL ACTION WRITTEN
May 28, 2013 CNRT
ASSIGNED TO EXAMINER
May 28, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 28, 2013 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
May 24, 2013 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 23, 2013 REPR